7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Saito K et al. | Conditional inactivation of TNFα-converting enzyme in chondrocytes results in an elongated growth plate and shorter long bones. | 2013 | PLoS ONE | pmid:23349978 |
Titanji K et al. | Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection. | 2014 | PLoS Pathog. | pmid:25393853 |
Lis GJ et al. | Influence of osteoclasts and osteoprotegerin on the mode of calcific degeneration of aortic valves. | 2016 | Pol. Arch. Med. Wewn. | pmid:27003233 |
Janda K et al. | Osteoprotegerin as a marker of cardiovascular risk in patients on peritoneal dialysis. | 2013 | Pol. Arch. Med. Wewn. | pmid:23535831 |
Nehring P et al. | Osteoprotegerin gene rs2073617 and rs3134069 polymorphisms in type 2 diabetes patients and sex‑specific rs2073618 polymorphism as a risk factor for diabetic foot. | 2013 | Pol. Arch. Med. Wewn. | pmid:23299915 |
Jasiewicz M et al. | Potential pathogenic role of soluble receptor activator of nuclear factor-ĸB ligand and osteoprotegerin in patients with pulmonary arterial hypertension. | 2014 | Pol. Arch. Med. Wewn. | pmid:25188298 |
Stajszczyk M | [Role of receptor activator of nuclear factor kappa B (RANK), its ligand (RANK-L) and osteoprotegerin (OPG) in bone metabolism]. | 2002 | Pol. Arch. Med. Wewn. | pmid:12600190 |
Adamczyk T et al. | Biomarkers of calcification and atherosclerosis in patients with degenerative aortic stenosis in relation to concomitant coronary artery disease. | 2012 | Pol. Arch. Med. Wewn. | pmid:22237719 |
Ambroszkiewicz J et al. | [Concentration of osteoprotegerin, bone formation and resorption markers in patients with phenylketonuria]. | 2008 | Pol. Merkur. Lekarski | pmid:18839616 |
Kmieć Z and Sokołowska I | [Role of tumor necrosis factor family ligands in the pathogenesis of rheumatoid arthritis--new therapeutical opportunities]. | 2007 | Pol. Merkur. Lekarski | pmid:17684931 |
Hen K et al. | [Osteoprotegerin--a new atherosclerosis marker]. | 2011 | Pol. Merkur. Lekarski | pmid:22097184 |
Ostrowska Z et al. | Circadian concentrations of free testosterone, selected markers of bone metabolism, osteoprotegerin and its ligand sRANKL in obese postmenopausal women. | 2011 | Postepy Hig Med Dosw (Online) | pmid:22100799 |
Ostrowska Z | [Menopause, obesity, and bone status]. | 2009 | Postepy Hig Med Dosw (Online) | pmid:19252463 |
Ostrowska Z et al. | Assessment of the relationship between melatonin, hormones of the pituitary-ovarian, -thyroid and -adrenocortical axes, and osteoprotegerin and its ligand sRANKL in girls with anorexia nervosa. | 2013 | Postepy Hig Med Dosw (Online) | pmid:23752595 |
Zdzisińska B and Kandefer-Szerszeń M | [The role of RANK/RANKL and OPG in multiple myeloma]. | 2006 | Postepy Hig Med Dosw (Online) | pmid:17013366 |
Majerczyk M et al. | [Osteoprotegerin as a marker of atherosclerosis and a prognostic factor in stroke]. | 2015 | Postepy Hig Med Dosw (Online) | pmid:27259222 |
Stanisławowski M and Kmieć Z | [The participation of RANK, RANKL and OPG in tumor osteolysis]. | 2009 | Postepy Hig Med Dosw (Online) | pmid:19502684 |
Ostrowska Z et al. | Â Dehydroepiandrosterone sulfate, osteoprotegerin and its soluble ligand sRANKL and bone metabolism in girls with anorexia nervosa. | 2012 | Postepy Hig Med Dosw (Online) | pmid:23001207 |
Wang Y et al. | Chicken receptor activator of nuclear factor-kappaB ligand induces formation of chicken osteoclasts from bone marrow cells and also directly activates mature osteoclasts. | 2008 | Poult. Sci. | pmid:18931186 |
Jiang S et al. | Changes of blood parameters associated with bone remodeling following experimentally induced fatty liver disorder in laying hens. | 2013 | Poult. Sci. | pmid:23687138 |
Fu YX et al. | Influence of osteoprotegerin on differentiation, activation, and apoptosis of Gaoyou duck embryo osteoclasts in vitro. | 2013 | Poult. Sci. | pmid:23687158 |
Ta HM et al. | Structure-based development of a receptor activator of nuclear factor-kappaB ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis. | 2010 | Proc. Natl. Acad. Sci. U.S.A. | pmid:21059944 |
Yasuda H et al. | Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. | 1998 | Proc. Natl. Acad. Sci. U.S.A. | pmid:9520411 |
Hsu H et al. | Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. | 1999 | Proc. Natl. Acad. Sci. U.S.A. | pmid:10097072 |
Shimamura M et al. | OPG/RANKL/RANK axis is a critical inflammatory signaling system in ischemic brain in mice. | 2014 | Proc. Natl. Acad. Sci. U.S.A. | pmid:24847069 |
Xiong L et al. | Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption. | 2015 | Proc. Natl. Acad. Sci. U.S.A. | pmid:25733894 |
Duheron V et al. | Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit. | 2011 | Proc. Natl. Acad. Sci. U.S.A. | pmid:21402940 |
Chen W et al. | Arthritogenic alphaviral infection perturbs osteoblast function and triggers pathologic bone loss. | 2014 | Proc. Natl. Acad. Sci. U.S.A. | pmid:24733914 |
Wei W et al. | Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor γ. | 2012 | Proc. Natl. Acad. Sci. U.S.A. | pmid:22315431 |
Krause U et al. | Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy. | 2010 | Proc. Natl. Acad. Sci. U.S.A. | pmid:20150512 |
Pearse RN et al. | Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression. | 2001 | Proc. Natl. Acad. Sci. U.S.A. | pmid:11562486 |
Raffai RL et al. | Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E. | 2001 | Proc. Natl. Acad. Sci. U.S.A. | pmid:11553788 |
Toraldo G et al. | IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. | 2003 | Proc. Natl. Acad. Sci. U.S.A. | pmid:12490655 |
Li JY et al. | Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand. | 2011 | Proc. Natl. Acad. Sci. U.S.A. | pmid:21187391 |
Baud'huin M et al. | A soluble bone morphogenetic protein type IA receptor increases bone mass and bone strength. | 2012 | Proc. Natl. Acad. Sci. U.S.A. | pmid:22761317 |
Cozzani M et al. | Transcription Factor Decoy (TFD) as a novel approach for the control of osteoclastic resorption. | 2005 | Prog Orthod | pmid:16276433 |
Malik P et al. | Bone mineral density and bone metabolism in patients with major depressive disorder without somatic comorbidities. | 2013 | Prog. Neuropsychopharmacol. Biol. Psychiatry | pmid:23380173 |
Kuroyanagi G et al. | Suppression by resveratrol of prostaglandin D2-stimulated osteoprotegerin synthesis in osteoblasts. | 2014 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:24813642 |
Fujita D et al. | Prostaglandin E2 induced the differentiation of osteoclasts in mouse osteoblast-depleted bone marrow cells. | 2003 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:12711253 |
Poulsen RC et al. | Long chain polyunsaturated fatty acids alter membrane-bound RANK-L expression and osteoprotegerin secretion by MC3T3-E1 osteoblast-like cells. | 2008 | Prostaglandins Other Lipid Mediat. | pmid:18077200 |
Li X et al. | Prostaglandin receptor EP2 mediates PGE2 stimulated hypercalcemia in mice in vivo. | 2002 | Prostaglandins Other Lipid Mediat. | pmid:12013525 |
Kuroyanagi G et al. | (-)-Epigallocatechin gallate synergistically potentiates prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts. | 2017 | Prostaglandins Other Lipid Mediat. | pmid:28163121 |
Blackwell KA et al. | Bone morphogenetic protein 2 enhances PGE(2)-stimulated osteoclast formation in murine bone marrow cultures. | 2009 | Prostaglandins Other Lipid Mediat. | pmid:19744575 |
Wiercinska-Drapalo A et al. | Transforming growth factor beta1 and prostaglandin E2 concentrations are associated with bone formation markers in ulcerative colitis patients. | 2005 | Prostaglandins Other Lipid Mediat. | pmid:16303613 |
Yamamoto N et al. | Resveratrol reduces prostaglandin E1-stimulated osteoprotegerin synthesis in osteoblasts: suppression of stress-activated protein kinase/c-Jun N-terminal kinase. | Prostaglandins Other Lipid Mediat. | pmid:25677506 | |
Armstrong AP et al. | RANKL acts directly on RANK-expressing prostate tumor cells and mediates migration and expression of tumor metastasis genes. | 2008 | Prostate | pmid:18008334 |
Hesry V et al. | Sensitivity of prostate cells to TRAIL-induced apoptosis increases with tumor progression: DR5 and caspase 8 are key players. | 2006 | Prostate | pmid:16541419 |
Burton DW et al. | Monitoring of skeletal progression of prostate cancer by GFP imaging, X-ray, and serum OPG and PTHrP. | 2005 | Prostate | pmid:15389781 |
Zheng Y et al. | Vitamin D deficiency promotes prostate cancer growth in bone. | 2011 | Prostate | pmid:21541977 |
Lin DL et al. | Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro. | 2001 | Prostate | pmid:11351351 |